Back to Journals Clinical Ophthalmology Volume 20 Glucagon-Like Peptide-1 Analogs Associated with a Reduced Risk of Legal Blindness in Type 2 Diabetics with Cardiovascular Risks Authors Jarrett E, Muayad J , Ryu BU, Lee AG, Gupta PK Received 1 December 2025 Accepted for publication 28 January 2026 Published 3 February 2026 Volume 2026:20 581826 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Yousef Fouad Ethan Jarrett, 1 Jawad Muayad, 2 Byoung U Ryu, 3 Andrew G Lee, 1 8 Praveena K Gupta 3 1 John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX, USA
Manufactured under strict quality controls, each capsule delivers a stable and bioactive compound, rigorously tested for purity and consistency to ensure reliable experimental results
In this study, both the GLP-1MK-801-treated mice and the calorie-restricted mice exhibited improved insulin sensitivity relative to the vehicle treatment and both monotherapy control groups (Extended Data Fig
Available from: Forslund T, Wettermark B (2019) Primrvrdens roll i sjukvrdssystemet [Internet]
Weight reduction achieved through consistent appetite regulation can also affect cardiovascular health
Open a fresh 3 mL or 10 mL syringe from sealed packaging and attach the larger gauge needle (18-20G)